Wells Fargo’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.95M Sell
514,721
-1,199
-0.2% -$8.21K ﹤0.01% 2790
2025
Q4
$1.02M Buy
515,920
+245,675
+91% +$557K ﹤0.01% 3954
2025
Q3
$665K Sell
270,245
-2,868
-1% -$7.39K ﹤0.01% 4097
2025
Q2
$721K Buy
273,113
+106,363
+64% +$286K ﹤0.01% 3906
2025
Q1
$502K Buy
166,750
+28,145
+20% +$85.3K ﹤0.01% 4095
2024
Q4
$355K Buy
138,605
+32,334
+30% +$135K ﹤0.01% 4416
2024
Q3
$395K Buy
106,271
+3,796
+4% +$17.6K ﹤0.01% 4143
2024
Q2
$648K Buy
102,475
+48,790
+91% +$322K ﹤0.01% 3746
2024
Q1
$288K Buy
53,685
+2,333
+5% +$10.6K ﹤0.01% 4245
2023
Q4
$258K Buy
51,352
+11,798
+30% +$37K ﹤0.01% 4310
2023
Q3
$66.8K Sell
39,554
-24,399
-38% -$49K ﹤0.01% 5021
2023
Q2
$178K Buy
63,953
+30,850
+93% +$87.2K ﹤0.01% 4650
2023
Q1
$60.2K Buy
33,103
+18,750
+131% +$58.3K ﹤0.01% 5066
2022
Q4
$72.8K Sell
14,353
-4,347
-23% -$23.9K ﹤0.01% 4699
2022
Q3
$93K Buy
18,700
+2,463
+15% +$11.2K ﹤0.01% 4649
2022
Q2
$61K Sell
16,237
-117,043
-88% -$470K ﹤0.01% 4929
2022
Q1
$748K Buy
133,280
+9,644
+8% +$59.2K ﹤0.01% 4121
2021
Q4
$752K Sell
123,636
-1,571
-1% -$11.8K ﹤0.01% 4347
2021
Q3
$1.22M Sell
125,207
-36,160
-22% -$398K ﹤0.01% 4070
2021
Q2
$2.3M Buy
161,367
+109,900
+214% +$1.82M ﹤0.01% 3559
2021
Q1
$1.22M Buy
51,467
+6,903
+15% +$179K ﹤0.01% 4105
2020
Q4
$594K Buy
44,564
+3,085
+7% +$29.7K ﹤0.01% 4400
2020
Q3
$287K Buy
41,479
+18,065
+77% +$180K ﹤0.01% 4749
2020
Q2
$287K Buy
23,414
+19,565
+508% +$110K ﹤0.01% 4689
2020
Q1
$11K Sell
3,849
-76
-2% -$381 ﹤0.01% 5733
2019
Q4
$15K Hold
3,925
﹤0.01% 5802
2019
Q3
$5K Sell
3,925
-1,707
-30% -$2.12K ﹤0.01% 6061
2019
Q2
$6K Sell
5,632
-12,978
-70% -$15K ﹤0.01% 6003
2019
Q1
$29K Sell
18,610
-2,695
-13% -$3.38K ﹤0.01% 5440
2018
Q4
$25K Sell
21,305
-4,907
-19% -$11.2K ﹤0.01% 5717
2018
Q3
$97K Buy
26,212
+1,690
+7% +$5.34K ﹤0.01% 5371
2018
Q2
$76K Buy
24,522
+1,238
+5% +$4.58K ﹤0.01% 5478
2018
Q1
$91K Sell
23,284
-230
-1% -$1.01K ﹤0.01% 5349
2017
Q4
$105K Sell
23,514
-1,561
-6% -$7.39K ﹤0.01% 5287
2017
Q3
$138K Buy
25,075
+4,161
+20% +$25.6K ﹤0.01% 5098
2017
Q2
$158K Buy
20,914
+2,400
+13% +$10.4K ﹤0.01% 4923
2017
Q1
$66K Sell
18,514
-5,000
-21% -$24.7K ﹤0.01% 5356
2016
Q4
$134K Sell
23,514
-6,380
-21% -$42.6K ﹤0.01% 4988
2016
Q3
$232K Buy
29,894
+11,820
+65% +$88.3K ﹤0.01% 4394
2016
Q2
$112K Buy
18,074
+1,584
+10% +$12.3K ﹤0.01% 4755
2016
Q1
$136K Buy
16,490
+9,666
+142% +$91.1K ﹤0.01% 4637
2015
Q4
$118K Buy
6,824
+4,471
+190% +$66.3K ﹤0.01% 4803
2015
Q3
$27K Buy
+2,353
New +$51.4K ﹤0.01% 5448

Other funds holding IBRX